Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy

Journal of Hypertension

Volumn 20, Issue 5, 2002, Pages 1015-1022

  Zanchetti, Alberto ^a   Hansson, Lennart ^a   Leonetti, Gastone ^a   Rahn, Karl Heinz ^a   Ruilope, Luis ^a   Warnold, Ingrid ^a   Wedel, Hans ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Angiotensin converting enzyme inhibitors; Antihypertensive therapy; Aspirin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BAMYCOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE;

ADULT; AGED; ANALGESIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DRUG CROSS REACTIVITY; DRUG MECHANISM; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SYSTOLIC BLOOD PRESSURE;

EID: 0036562978     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200205000-00038     Document Type: Article

References (26)

1. Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension
2. The antihypertensive effect of captopril in essential hypertension: Relationship to prostaglandins and the kallikrein-kinin system
3. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension
4. Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin
5. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction
6. Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan
7. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors
8. Combining salicylate and enalapril in patients with coronary artery disease and heart failure
9. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
10. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure
11. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: Results of a double-blind, randomized comparative trial
12. Effects of acetylsalicylic acid on renal function in patients with chronic heart failure
13. Angiotensin-converting enzyme inhibitors and renal function in heart failure
14. Antiplatelet agents and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial
15. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: Subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
16. Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?
17. Interaction between aspirin and ACE inhibitors in patients with heart failure
18. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
19. Validation of an oscillometric blood pressure measuring device: A substudy of the HOT study
20. Prediction of creatinine clearance from serum creatinine
21. Risk assessment and treatment benefit in the intensively treated patients of the Hypertension Optimal Treatment (HOT) study
22. Effects of individual risk factors on the incidence of cardiovascular events in the hypertensive patients of the Hypertension Optimal Treatment (HOT) study
23. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
24. Renal function and intensive lowering of the blood pressure in the hypertensive participants of the Hypertension Optimal Treatment (HOT) study
25. Thrombosis Prevention Trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
26. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice